References
- “New Drugs and Clinical Trials Rules, 2019 – A Regulatory Overview.” India Corporate Law (A Cyril Amarchand Mangaldas Blog). 2019. Accessed 1 August 2020. https://corporate.cyrilamarchandblogs.com/2019/07/new-drugs-clinical-trials-rules-2019-regulations-india/
- “About Us.” South African Health Products Regulatory Authority (SAHPRA). 2020. Accessed 27 July 2020. https://www.sahpra.org.za/who-we-are/
- “About the NCCR.” National Committee for Clinical Research (NCCR). 2020 Accessed 16 August 2020. http://www.nccr.gov.my/index.cfm?menuid=2
- ABPI (Association of the British Pharmaceutical Industry). 2014. Clinical Trial Compensation Guidelines. London: Association of the British Pharmaceutical Industry, ABPI.
- Agar, G., and L. J. Burgess. 2018. “What the Contract Does Not Say… A Current Analysis of What’s Missing in Clinical Trial Agreements.” South African Journal of Bioethics and Law 11 (1): 20–23. doi:https://doi.org/10.7196/SAJBL.2018.v11i1.00603.
- Ashwin, S., Biplab, L. and Kartik, J. 2019. “New Drugs and Clinical Trials Rules, 2019 – A Regulatory Overview.„ India Corporate Law (A Cyril Amarchand Mangaldas Blog). Accessed 01-Aug-2020. https://corporate.cyrilamarchandblogs.com/2019/07/new-drugs-clinical-trials-rules-2019-regulations-india/
- Avilés, M. A. R. 2014. “Compensation of Research-related Injuries in the European Union.” European Journal of Health Law 21 (5): 473–487. doi:https://doi.org/10.1163/15718093-12341332.
- Benatar, S. R. 2001. “Distributive Justice and Clinical Trials in the Third World.” Theoretical Medicine and Bioethics 22 (3): 169–176. doi:https://doi.org/10.1023/A:1011419820440.
- CDSC0 (Central Drugs Standard Control Organization). 2005.“Gazette Notfication - GSR 32(E): Drugs and Cosmetics (IIND Amendment) Rules.” Ministry of Health and Family Welfare, Central Drugs Standard Control Organization, Government of India. India
- CDSCO (Central Drugs Standard Control Organization). 2001. Good Clinical Practices for Clinical Research in India. India: Central Drugs Standard Control Organization, Ministry of Health and Family Welfare, Government of India.
- Chawan, V. S., K. V. Gawand, and A. M. Phatak. 2015. “Impact of New Regulations on Clinical Trials in India.„ International Journal of Clinical Trials 2(3):56-58. https://doi.org/https://dx.doi.org/10.18203/2349-3259.ijct20150592
- Childress, J. F. 1976. “Compensating Injured Research Subjects: I. The Moral Argument.” The Hastings Center Report 6 (6): 21–27. doi:https://doi.org/10.2307/3561144.
- Chingarande, G. R., and K. Moodley. 2018. “Disparate Compensation Policies for Research Related Injury in an Era of Multinational Trials: A Case Study of Brazil, Russia, India, China and South Africa.” BMC Medical Ethics 19 (1): 8. doi:https://doi.org/10.1186/s12910-018-0244-y.
- “Clinical Research.” School of Medicine, University of Virginia, Accessed 25 August 2020. https://research.med.virginia.edu/clinicalresearch/what-is-medical-research/
- CIOMS (Council for International Organizations of Medical Sciences). 2016. International Ethical Guidelines for Health-related Research Involving Humans. 4th ed. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS).
- Coleman, C. H. 2005. “Duties to Subjects in Clinical Research.” Vanderbilt Law Review 58: 387.
- CRM (Clinical Research Malaysia). 2017. Malaysian Phase I Clinical Trial Guidelines. Kuala Lumpur, Malaysia: Clinical Research Malaysia.
- “Clinical Trials in India (Part 1): The Early Years of Regulation.” Bagchi Law. 2017. Accessed 1 August 2020. https://bagchilaw.com/clinical-trials-india-part-1-early-years-regulation/
- “Clinical Research Versus Medical Treatment.” US Food Drug Administration (US FDA). 2018. Accessed 10 August 2020. https://www.fda.gov/patients/clinical-trials-what-patients-need-know/clinical-research-versus-medical-treatment
- “Clinical Trials versus Studies: Is There a Difference?” Cystic Fibrosis Foundation. 2020. Accessed 30 August 2020. https://www.cff.org/Research/Developing-New-Treatments/Clinical-Trials/Clinical-Trials-101/Clinical-Trials-Versus-Studies-Is-There-a-Difference/
- DoH SA (Department of Health South Africa). 2006. Guidelines for Good Practice in the Conduct of Clinical Trials with Human Participants in South Africa. Pretoria, South Africa: Department of Health, DoH.
- Dyer, O. 2006. “Firm Involved in Drug Trial Fiasco Files for Bankruptcy.” The BMJ 333 (7559): 114.
- Funck-Brentano, C., and M. Joël. 2016. “The BIAL/Biotrial Case of Death of a Human Volunteer in the First-in-human Study of BIA 10-2474: Are We Missing the Fundamentals?” La Presse Médicale 45 (9): 719–722. doi:https://doi.org/10.1016/j.lpm.2016.08.003.
- Gainotti, S., and C. Petrini. 2010. “Insurance Policies for Clinical Trials in the United States and in Some European Countries.” Journal of Clinical Research & Bioethics 1 (1). doi:https://doi.org/10.4172/2155-9627.1000101.
- Hawkins, J. S., and E. J. Emanuel. 2008. Exploitation and Developing Countries:. ethics of clinical research. Princeton, USA: Princeton University Press.
- Henry, L. M. 2013. “Moral Gridlock: Conceptual Barriers to No-fault Compensation for Injured Research Subjects.” The Journal of Law, Medicine & Ethics 41 (2): 411–423. doi:https://doi.org/10.1111/jlme.12052.
- Henry, L. M., M. E. Larkin, and E. R. Pike. 2015. “Just Compensation: A No-fault Proposal for Research-related Injuries.” Journal of Law and the Biosciences 2 (3): 645–668.
- Henry, L.M. 2013. “Moral Gridlock: Conceptual Barriers to No-Fault Compensation for Injured Research Subjects.“ The Journal of Law, Medicine & Ethics 41 (2): 411–423 doi: https://doi.org/10.1111/jlme.12052
- Hoffman, S. 2000. “The Use of Placebos in Clinical Trials: Responsible Research or Unethical Practice.” Connecticut Law Review 33: 449.
- Hope, T. 1997. “Compensating Subjects of Medical Research.” Journal of Medical Ethics 23 (3): 131. doi:https://doi.org/10.1136/jme.23.3.131.
- Hugh, T. B., and G. Douglas Tracy. 2002. “Hindsight Bias in Medicolegal Expert Reports.” Medical Journal of Australia 176 (6): 277–278. doi:https://doi.org/10.5694/j.1326-5377.2002.tb04407.x.
- “I Am Aware: Understanding Clinical Trials.” Clinical Research Malaysia. Accessed 31 August 2020. https://clinicalresearch.my/iamaware/understanding-clinical-trials/
- ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use). 2016. Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice. Geneva, Switzerland: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
- “Introduction.” Central Drugs Standard Control Organization (CDSCO). Accessed 1 August 2020. https://cdsco.gov.in/opencms/opencms/en/About-us/Introduction/
- ICMR (Indian Council of Medical Research). 2017. National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. New Delhi, India: Indian Council of Medical Research.
- Ismail, R. 2015. “Product Liability under the Malaysian Consumer Protection Act 1999: Justice for Consumers?” International Business Management 9 (6):1290–1296.
- Jain, P., and R. Chauhan. 2019. “India’s New Drugs and Clinical Trials Rules: An Industry Perspective.” Regulatory Focus.Regulatory Affairs Professionals Society. https://www.raps.org/news-and-articles/news-articles/2019/7/indias-new-drugs-and-clinical-trials-rules-an-in
- Jansson, R. L. 2003. “Researcher Liability for Negligence in Human Subject Research: Informed Consent and Researcher Malpractice Actions.” Washington Law Review 78 (1): 229.
- Kamalo, P. D., L. Manda-Taylor, and S. Rennie. 2016. “Appropriateness of No-fault Compensation for Research-related Injuries from an African Perspective: An Appeal for Action by African Countries.” Journal of Medical Ethics 42 (8): 528–533. doi:https://doi.org/10.1136/medethics-2014-102246.
- Kang, G. 2012. “Putting Patients First: Draft Guidelines for Compensation for Research-related Injury in Clinical Trials in India.” Indian Journal of Medical Ethics 9 (2): 77–79. doi:https://doi.org/10.20529/IJME.2012.026.
- Kassim, P.N. 2014.“No-fault compensation for medical injuries: Trends and challenges.„ Medicine & Law. 33: 21–54
- Kaur, S. 2011. The Adequacy of the Ethics Review Process in Malaysia: Protection of the Interests of Mentally Incapacitated Adults Who Enrol in Clinical Trials. London, England: University College London.
- Maisarah, A. S., M. K. Nurul Ajilah, M. R. Siti Amalina, and M. N. Norazuroh. 2016. “Short Review: Implementation of Biomedical Ethics in Malaysia.” Health and the Environment Journal 7 (2): 54–76.
- “Malaysia’s Clinical Research Ecosystem.” Applied Clinical Trials. Accessed 16 February 2020. http://www.appliedclinicaltrialsonline.com/malaysia-s-clinical-research-ecosystem?pageID=1
- “Malaysia an Ideal Clinical Trial Site: Health Ministry Sec-gen.” TheSunDaily. 2019. Accessed 18 February 2020. https://www.thesundaily.my/local/malaysia-an-ideal-clinical-trial-site-health-ministry-sec-gen-EL1805336
- Mamotte, N., D. Wassenaar, and N. Singh. 2013. “Compensation for Research-related Injury in NIH-sponsored HIV/AIDS Clinical Trials in Africa.” Journal of Empirical Research on Human Research Ethics 8 (1): 45–54. doi:https://doi.org/10.1525/jer.2013.8.1.45.
- Manning, J. M. 2017. “Does the Law on Compensation for Research-related Injury in the UK, Australia, and New Zealand Meet Ethical Requirements?” Medical Law Review 25 (3): 397–427. doi:https://doi.org/10.1093/medlaw/fwx019.
- MDA (Medical Device Authority). 2016. Notification of Exemption from Registration of Medical Devices for the Purpose of Clinical Research or Performance Evaluation. Putrajaya: Medical Device Authority.
- Mello, M. M., D. M. Studdert, and T. A. Brennan. 2003. “The Rise of Litigation in Human Subjects Research.” Annals of Internal Medicine 139 (1): 40–45. doi:https://doi.org/10.7326/0003-4819-139-1-200307010-00011.
- Mendick, R. 2008. “Elephant Man Drug Trial Victim Set to Win £2m Payout for Injuries.” Evening Standard. Accessed 4 June 2020. https://www.standard.co.uk/news/elephant-man-drug-trial-victim-set-to-win-2m-payout-for-injuries-6627033.html
- Mikkonen, M. 2004. “Prevention of Patient Injuries: The Finnish Patient Insurance Scheme.” Medicine and Law 23 (2): 251.
- Miller, F. G., and H. Brody. 2003. “A Critique of Clinical Equipoise: Therapeutic Misconception in the Ethics of Clinical Trials.” The Hastings Center Report 33 (3): 19–28. doi:https://doi.org/10.2307/3528434.
- CDSC0 (Central Drugs Standard Control Organization).“Gazette Notfication - GSR 32(E): Drugs and Cosmetics (IIND Amendment) Rules; 2005.” In edited by, Ministry of Health and Family Welfare Central Drugs Standard Control Organization, Government of India. India: Central Drugs Standard Control Organization, Ministry of Health and Family Welfare, Government of India.
- MMC (Malaysian Medical Council). 2006. MMC Guideline - Clinical Trials and Biomedical Research. Kuala Lumpur: Malaysian Medical Council.
- Mokhtar, F. S., and R. Ismail. 2013. “Medical Product Liability under the Consumer.” The Social Sciences 8 (6): 565–573.
- Mokhtar, F. S., R. Ismail, A. M. M. Salleh, and Z. Z. Ariffin. 2016. “Medical Product Liability in Malaysia: The Need of Legislative Intervention.” Social Sciences 11: 5162–5165.
- Morreim, E. H. 2003. “Medical Research Litigation and Malpractice Tort Doctrines: Courts on a Learning Curve.” Houston Journal of Health Law & Policy 4: 1.
- Morreim, E. H. 2004. “Litigation in Clinical Research: Malpractice Doctrines versus Research Realities.” The Journal of Law, Medicine & Ethics 32 (3): 474–484. doi:https://doi.org/10.1111/j.1748-720X.2004.tb00160.x.
- MREC (Medical Rsearch & Ethics Committee). 2006. Guidelines for Ethical Review of Clinical Research or Research Involving Human Subjects. Kuala Lumpur, Malaysia: Medical Review & Ethics Committee (MREC), Ministry of Health Malaysia.
- MREC (Medical Rsearch & Ethics Committee). 2019. Template for Patient Information Sheet and Informed Consent Form (For Adult Subjects and Interventional Studies). Kuala Lumpur, Malaysia: Medical Research & Ethics Committees.
- Munshi, R., and U. Thatte. 2013. “Compensation for Research Related Injury.” Perspectives in Clinical Research 4 (1): 61–69. doi:https://doi.org/10.4103/2229-3485.106392.
- NCCR (National Committee for Clinical Research). 2018. Malaysian Guideline for Good Clinical Practice 4th Edition. Petaling Jaya, Malaysia: National Committee for Clinical Research (NCCR).
- New Drugs and Clinical Trials Rules 2019. India.
- Niehoff, N. M., and W. Madeleine. 2015. The Big Pharma & the Elephant Man: A Qualitative Study on the TeGenero Crisis Communication. Uppsala University.Uppsala, Sweden.
- NPRA (National Pharmaceutical Regulatory Agency). 2020. Malaysian Guideline for Application of Clinical Trial Import Licence and Clinical Trial Exemption Edition 7.0. Petaling Jaya, Malaysia: National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia.
- “Participating in Clinical Trials.” Singapore Health Sciences Authority (HSA). Accessed 1 March 2020. https://www.hsa.gov.sg/clinical-trials/participating
- Parliament of India Department-Related Parliamentary Standing Committee on Health and Family Welfare. 2012. Fifty-Ninth Report on the Functioning of the Central Drug Standard Control Organisation, CDSCO. New Delhi, India: Department-Related Parliamentary Standing Committee on Health and Family Welfare, Parliament of India.
- Pike, E. R. 2012. “Recovering from Research: A No-fault Proposal to Compensate Injured Research Participants.” American Journal of Law & Medicine 38 (1): 7–62. doi:https://doi.org/10.1177/009885881203800101.
- Productivity Commission. 2011. Disability care and support report No. 54. Canberra: Australian Government.
- Resnik, D. B. 2006. “Compensation for Research-related Injuries, Ethical and Legal Issues.” The Journal of Legal Medicine 27 (3): 263–287. doi:https://doi.org/10.1080/01947640600870866.
- Robertson, J. A. 1976. “Compensating Injured Research Subjects: II. The Law.” The Hastings Center Report 6 (6): 29–31. doi:https://doi.org/10.2307/3561146.
- SAHPRA (South African Health Products Regulatory Authority). 2019. Liability Insurance for Clinical Trials. Pretoria, South Africa: South African Health Products Regulatory Authority, SAHPRA.
- SCRPM (Society of Clinical Research Professionals in Malaysia). 2016. A Guide to Conducting Clinical Trials in Malaysia. 1st ed. Petaling Jaya, Malaysia: Society of Clinical Research Professionals in Malaysia.
- See, H. Y., M. S. Mohamed, S. N. M. Noor, and W. Y. Low. 2019. “Addressing Procedural Challenges of Ethical Review System: Towards a Better Ethical Quality of Clinical Trials Review in Malaysia.” Accountability in Research 26 (1): 49–64. doi:https://doi.org/10.1080/08989621.2018.1556646.
- Singh, J. A. 2013. “India’s Regulatory Reforms on Compensation for Clinical Trial Injuries and Deaths: Urgent Need for Revisiting.” Indian Journal of Medical Ethics 10 (3): 195–197 doi:https://doi.org/10.20529/IJME.2013.057.
- Slack, C., P. Singh, A. Strode, and Z. Essack. 2012. “Compensation for Research-related Injury in South Africa: A Critique of the Good Clinical Practice (GCP) Guidelines.” South African Journal of Bioethics and Law 5 (2): 91–94. doi:https://doi.org/10.7196/sajbl.211.
- Steinbrook, R. 2006. “Compensation for Injured Research Subjects.” New England Journal of Medicine 354 (18): 1871–1873. doi:https://doi.org/10.1056/NEJMp068080.
- Strode, A., and P. P. Singh. 2014. “Compensation for Research-related Harm: The Implications of Venter V Roche Products (Pty) Limited and Others for Research Ethics Committees.” SAMJ: South African Medical Journal 104 (11): 759–761. doi:https://doi.org/10.7196/SAMJ.8596.
- Studdert, D. M., and T. A. Brennan. 2001. “No-fault Compensation for Medical Injuries: The Prospect for Error Prevention.” Jama 286 (2): 217–223. doi:https://doi.org/10.1001/jama.286.2.217.
- “Swasthya Adhikar Manch, Indore & Anr. Vs. Ministry of Health & Welfare and Ors.” W.P. (C) 33/2012. India: Supreme Court of India.
- Tangwa, G. B. 2001. “Moral Agency, Moral Worth and the Question of Double Standards in Medical Research in Developing Countries.” Developing World Bioethics 1 (2): 156–162. doi:https://doi.org/10.1111/1471-8847.00022.
- Thatte, U. M., R. Kulkarni-Munshi, and S. A. Kalekar. 2009. “Review of Policies for Injuries to Research Participants in India.” Journal of Medical Ethics 35 (2): 133–139. doi:https://doi.org/10.1136/jme.2008.025155.
- Urooj, M., G. M. Husain, M. A. Khan, and M. H. Kazmi. 2017. “Compensation to Clinical Trial Participants in India: A Gap Analysis.” International Journal of Pharmaceutical Investigation 7 (2): 41. doi:https://doi.org/10.4103/jphi.JPHI_31_17.
- “Venter V Roche Products (Pty) Ltd.” 2014. [2014] ZAWCHC 157. Cape Town, South Africa: High Court of South Africa Western Cape
- Weisbrot, D., and K. J. Breen. 2012. “A No‐fault Compensation System for Medical Injury Is Long Overdue.” Medical Journal of Australia 197 (5): 296–298. doi:https://doi.org/10.5694/mja12.10322.
- Wood, A. J. J., and J. Darbyshire. 2006. “Injury to Research Volunteers — The Clinical-Research Nightmare.” New England Journal of Medicine 354 (18): 1869. doi:https://doi.org/10.1056/NEJMp068082.
- Zahiid, S. J. 2017. “Clinical trials: Just how safe are they?” Malaymail. Accessed 24 August 2020. https://www.malaymail.com/news/malaysia/2017/07/18/clinical-trials-just-how-safe-are-they/1423741
- Zahiid, S. J. 2017. “Clinical Trials: Just How Safe are They?” Malaymail. Accessed 24 August 2020. https://www.malaymail.com/news/malaysia/2017/07/18/clinical-trials-just-how-safe-are-they/1423741